Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

ClinicalTrials.gov ID: NCT05913232

Public ClinicalTrials.gov record NCT05913232. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b Randomized, Double-masked, Active-controlled, Dose-response Study of the Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension

Study identification

NCT ID
NCT05913232
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
D. Western Therapeutics Institute, Inc.
Industry
Enrollment
201 participants

Conditions and interventions

Interventions

  • H-1337 0.6% Drug
  • H-1337 1.0% Drug
  • H-1337 Placebo Drug
  • Timolol 0.5% Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 27, 2023
Primary completion
Aug 28, 2024
Completion
Aug 28, 2024
Last update posted
Aug 26, 2025

2023 – 2024

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Global Research Management Glendale California 91204
Skyline Vision Clinic and Laser Center Colorado Springs Colorado 80907
Central Florida Eye Associates Lakeland Florida 33805
Shettle Eye Research, Inc. Largo Florida 33773
Dixon Eye Care Albany Georgia 31701
Coastal Research Associates, LLC Roswell Georgia 30076
Rochester Ophthalmological Group, PC Rochester New York 14618
University Eye Specialists Maryville Tennessee 37803
Vistar Eye Center Roanoke Virginia 24011

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05913232, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 26, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05913232 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →